Nocturnal enuresis in children: an analysis of etiological factors and treatment effectiveness (a pilot study)
Litsenziya: cc-by
Annotatsiya
Background. Nocturnal enuresis (NE) is a common pediatric disorder that significantly affects emotional well-being and family quality of life. Despite its high prevalence, the pathogenesis of NE remains incompletely understood. Growing evidence indicates that NE is not solely a urological issue but rather a multifactorial neurodevelopmental disorder involving cortical immaturity, sleep-arousal dysfunction, and altered neurohormonal regulation. Aim. To identify neurophysiological and psychosocial contributors to nocturnal enuresis and to assess the effectiveness of therapeutic interventions. Methods. A prospective longitudinal pilot study was conducted at Alfraganus University Hospital (Tashkent, Uzbekistan) between June 2024 and February 2025, involving 47 children aged 5–15 years (mean age 9.6 ± 2.1 years) diagnosed with NE. Clinical, neurological, and psychological assessments were performed, including electroencephalography (EEG), magnetic resonance imaging (MRI), and the Test of Variables of Attention (TOVA). Serum vitamin D and vitamin B12 levels were measured. Statistical analyses were performed using SPSS version 25, applying the t-test, chi-square test, and Pearson correlation analysis. Treatment consisted of desmopressin for primary NE (administered for one month) and nootropic and anticholinergic therapy for secondary NE (administered for two months), followed by EEG monitoring. Desmopressin was administered at bedtime with evening fluid restriction, and treatment was temporarily discontinued during intercurrent illness to minimize the risk of hyponatremia. Results. A positive family history of NE was observed in 89% of cases. Psychological trauma was identified in 93.8% of children with secondary NE, while 68% had evidence of perinatal central nervous system injury. EEG findings demonstrated reduced alpha activity and increased delta activity, consistent with delayed cortical maturation. Vitamin D deficiency (<20 ng/mL) was detected in 48.8% of participants, and vitamin B12 deficiency in 25.6%; both deficiencies showed a significant inverse correlation with NE frequency (r = –0.45, p < 0.01). Treatment with desmopressin and nootropic therapy resulted in a significant reduction in the number of wet nights (p < 0.05), along with improvements in EEG parameters and anxiety levels. Conclusion. Nocturnal enuresis in children is a multifactorial neurodevelopmental disorder associated with impaired arousal mechanisms and micronutrient deficiencies. Early diagnosis, multidisciplinary management, and correction of vitamin D and vitamin B12 deficiencies may enhance treatment outcomes. Personalized therapeutic strategies integrating pharmacological, neurophysiological, and behavioral approaches have the potential to improve neurological maturation and quality of life in affected children.
Hali tarjima qilinmagan